Search Results - Mijušković, Ž.

Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial by Livingstone, Elisabeth (Author) , Gogas, H. J. (Author) , Kandolf, L. (Author) , Meier, F. (Author) , Eigentler, T. K. (Author) , Ziemer, M. (Author) , Terheyden, P. (Author) , Gesierich, A. (Author) , Herbst, R. A. (Author) , Kähler, K. C. (Author) , Ziogas, D. C. (Author) , Mijušković, Ž. (Author) , Garzarolli, M. (Author) , Garbe, C. (Author) , Roesch, A. (Author) , Ugurel, S. (Author) , Gutzmer, R. (Author) , Gaudy-Marqueste, C. (Author) , Kiecker, F. (Author) , Utikal, Jochen (Author) , Hartmann, M. (Author) , Miethe, S. (Author) , Eckhardt, S. (Author) , Zimmer, L. (Author) , Schadendorf, Dirk (Author) ,

• kostenfrei
• kostenfrei

Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positiv... by Livingstone, Elisabeth (Author) , Gogas, H. (Author) , Kandolf-Sekulovic, L. (Author) , Meier, F. (Author) , Eigentler, T. K. (Author) , Ziemer, M. (Author) , Terheyden, P. A. M. (Author) , Gesierich, A. H. (Author) , Herbst, R. A. (Author) , Kähler, K. C. (Author) , Ziogas, D. C. (Author) , Mijuskovic, Z. (Author) , Garzarolli, M. (Author) , Garbe, C. (Author) , Roesch, A. (Author) , Ugurel, S. (Author) , Gutzmer, R. (Author) , Grob, J. J. (Author) , Kiecker, F. (Author) , Utikal, Jochen (Author) , Windemuth-Kieselbach, C. (Author) , Eckhardt, S. (Author) , Zimmer, L. (Author) , Schadendorf, Dirk (Author) ,

• lizenzpflichtig
• lizenzpflichtig